ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintSite TitleTitle ChevronIcon Twitter
Process Industries

Mitsubishi Chemical Holdings Corp.

Business Summary

Mitsubishi Chemical Holdings Corp. engages in the management of its group companies. It operates through the following segments: Functional Products, Chemicals, Industrial Gas, and Healthcare. The Functional Products segment sells electronics, displays, films, environment and life solutions, molding materials, polymers, chemicals, and new energy to domestic and overseas customers. The Chemicals segment markets methyl methacrylate, petrochemicals, and carbon. The Industrial Gas segment offers gas for the steel, chemical, and electronics industries. The Healthcare segment manufactures and sells pharmaceuticals, diagnostic reagents, and clinical testing products. The company was founded on October 3, 2005 and is headquartered in Tokyo, Japan.

Financial Highlights

Mar 2020 JPYUSD
Revenue3,580.51B32,931.56M
Gross Profit987,263M9,080.30M
Operating income186,691M1,717.08M
Income before tax122,003M1,122.11M
Net income37,185M342.00M
EBITDA426,515M3,922.85M
Diluted EPS35.200.32
Dividends Per Share320.29
Total Assets5,132.14B47,539.70M
Total liabilities3,681.32B34,100.50M
Total equity1,170.22B10,839.90M
Operating cash flow452,003M4,157.27M
Currency in JPYCurrency in USD

Historical Data

 Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Revenue 3,543.35B 3,376.05B 3,724.40B 3,840.34B 3,580.51B
Gross Profit 1,015.04B 1,009.39B 1,120.06B 1,074.52B 987,263M
Operating income 295,965M 287,903M 355,745M 297,750M 186,691M
Income before tax 238,808M 241,379M 344,077M 284,846M 122,003M
Net income 125,227M 153,673M 211,788M 167,058M 37,185M
EBITDA 478,621M 461,943M 534,640M 497,082M 426,515M
Diluted EPS 35.03 105.95 136.05 110.04 35.20
Dividends Per Share 15 20 32 40 32
Total Assets 4,223.77B 4,463.54B 4,701.41B 5,572.50B 5,132.14B
Total liabilities 2,627.62B 2,765.35B 2,781.92B 3,546.65B 3,681.32B
Total equity 972,197M 1,091.39B 1,285.75B 1,377.94B 1,170.22B
Operating cash flow 299,612M 396,643M 397,940M 415,575M 452,003M
 Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Revenue 29,507.20M 31,176.79M 33,603.94M 34,630.52M 32,931.56M
Gross Profit 8,452.80M 9,321.47M 10,105.90M 9,689.62M 9,080.30M
Operating income 2,464.64M 2,658.69M 3,209.75M 2,684.98M 1,717.08M
Income before tax 1,988.66M 2,229.05M 3,104.47M 2,568.61M 1,122.11M
Net income 1,042.82M 1,419.12M 1,910.88M 1,506.45M 342.00M
EBITDA 3,985.70M 4,265.89M 4,823.85M 4,482.46M 3,922.85M
Diluted EPS 0.29 0.97 1.22 0.99 0.32
Dividends Per Share 0.12 0.18 0.28 0.36 0.29
Total Assets 37,579.73M 40,056.95M 44,206.99M 50,345.65M 47,539.70M
Total liabilities 23,378.46M 24,816.92M 26,158.19M 32,042.77M 34,100.50M
Total equity 8,649.82M 9,794.47M 12,089.79M 12,449.26M 10,839.90M
Operating cash flow 2,495.01M 3,662.86M 3,590.46M 3,747.47M 4,157.27M

Valuation Measures

Mar 2020
PER16.87
ROA0.69%
ROE2.91%
Operating margin5.21%
Profit margin1.03%

Key executives

  • President & Director: Hitoshi Ochi
  • CFO, Director & Managing Executive Officer: Hidefumi Date
  • Director & Chief Compliance Officer: Ken Fujiwara
  • Group Manager-Business Administration Office: Hajime Komori
  • Manager-Business Administration: Motohiro Oki

Shareholders

  • Mitsubishi Chemical Holdings Corp. (5.5%)
  • Meiji Yasuda Life Insurance Co. (4.2%)
  • Nomura Asset Management Co., Ltd. (3.9%)
  • Mitsubishi UFJ Trust & Banking Pension Fund (3.8%)
  • Asset Management One Co., Ltd. (3.6%)
  • Nippon Life Insurance Co. (2.8%)
  • BlackRock Fund Advisors (2.5%)
  • The Vanguard Group, Inc. (2.4%)
  • Mitsubishi UFJ Financial Group, Inc. (1.8%)
  • Daiwa Asset Management Co. Ltd. (1.5%)

Contact Details

Related Companies

  • Mitsubishi Chemical Hldgs. Restricted Stock Compensation Plan
  • MCPP Innovation LLC
  • Diamond Edge Ventures, Inc.
  • Mitsubishi Chemical Holdings Board Incentive Plan
  • Verbatim Corp.
  • Mitsubishi Chemical Imaging Corp.
  • MEP Technical Center Asia Ltd.
  • MCC Group Holdings (UK) Ltd.
  • Life Science Institute, Inc.
  • Mitsubishi Chemical Holdings Europe GmbH
  • AmperVertice Lda.
  • Mitsubishi Plastics Agricultural Film Technology Wuxi Co. Ltd.
  • Ryoukou Industrial Co. Ltd.
  • Mitsubishi Chemical Analysis Co. Ltd.
  • Rhombic Corp. (Japan)
  • Verbatim Southern Africa
  • Mitsubishi Chemical Holdings (Beijing) Co. Ltd.
  • Tai Young High Tech Co. Ltd.
  • MCC PTA Asia Pacific Pte Ltd.
  • Mitsubishi Chemical Holdings America, Inc.
  • Advanced Plastics Compounds Singapore Pte Ltd.
  • PT Mitsubishi Chemical Indonesia
  • Yoshitomi Engineering Ltd.
  • Mitsubishi Chemical Hldgs Business Association
  • Kaiteki Institute, Inc.
  • Mitsubishi Chemical Infonics Pte Ltd.
  • Nihon Gosei Sangyo KK
  • Ryoju Corp.
  • Mitsubishi Chemical Agri, Inc.
  • Japan Unipet Co. Ltd.

Competitors

  • DuPont de Nemours, Inc.
  • Evonik Industries AG
  • Sumitomo Chemical Co., Ltd.
  • LG Chem Ltd.
  • Eastman Chemical Company
  • Arkema SA
  • Kolon Industries, Inc.
  • Covestro AG
  • Celanese Corporation
  • Kolon Life Science Inc.
  • Sinochem International Corporation Class A
  • Polyplex (Thailand) Public Co. Ltd.
  • Chemocentryx, Inc.
  • UFlex Limited
  • Adamas Pharmaceuticals, Inc.
  • Acorda Therapeutics, Inc.
  • Linde plc
  • Fuwei Films (Holdings) Co., Ltd.
  • Cytokinetics, Incorporated
  • Shenzhen Capchem Technology Co., Ltd. Class A
  • Tredegar Corporation
  • Voyager Therapeutics, Inc.
  • FibroGen, Inc.
  • Valneva SE
  • BiondVax Pharmaceuticals Ltd. Sponsored ADR
  • Cabaletta Bio, Inc.
  • GrafTech International Ltd.
  • Green Seal Holding Ltd.
  • Axovant Gene Therapies Ltd.
  • OCI Partners LP
Last Updated on 25 Sep, 2020

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends July 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media